What's new

Summary of opinion: Cabometyx, 19/06/2025 Positive

Summary of opinion: Cabometyx, 19/06/2025 Positive

Jun 20, 2025 - 12:25
 0
Summary of opinion: Cabometyx, 19/06/2025 Positive
Summary of opinion: Cabometyx, 19/06/2025 Positive
Read More

Tags:

Previous Article

First treatment against liver scarring caused by a type of ‘fatty liver disease’

Next Article

Human medicines European public assessment report (EPAR): Eiyzey, aflibercept, S...

Related Posts

Human medicines European public assessment report (EPAR): Filsuvez, birch bark extract, Date of authorisation: 21/06/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Jyseleca, filgotinib, Date of authorisation: 24/09/2020, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 10, 2025  0

Human medicines European public assessment report (EPAR): Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz), levodopa,carbidopa,entacapone, Date of authorisation: 11/11/2013, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0